Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents
Clinical trial NCT03567291 · TERMINATED
Trial details
- NCT number
- NCT03567291
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2020-05-15
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.